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INTRODUCTION
Autoimmune diseases are often caused by the inap-
propriate activation of CD4 T cells specific for
peripheral self-antigens. Since these cells recognize
their target antigens in the context of MHC class II
molecules on the surface of specialized antigen-
presenting cells (APC), the induction of immunity, or
alternatively tolerance, of CD4 T cells depends on
the release of antigens from peripheral tissues and
uptake by APC. To study this process, transgenic
mouse models have been established in which
experimental self-antigens are expressed under the
control of tissue-specific promoters. With the avail-
ability of T-cell-receptor (TCR)-transgenic mice spe-
cific for the respective antigen, the T-cell response
toward such neo self-antigens can be followed
directly during the development of the immune
system (for review, see Himmerling et al., 1993;
Kruisbeek and Amsen, 1996; Mondino et al., 1996)
The transgenic mouse model described here has
been originally established by D. Hanahan with the
intention to study tissue-specific tumorigenesis fol-
lowing expression of a viral oncogene, the SV40 T
antigen (Tag), under control of the rat insulin II gene
promoter (RIP) (Hanahan, 1985). Independent lines
of RIP-Tag transgenic mice were later shown to
mount characteristic immune responses toward Tag,
depending on the onset and level of Tag expression
during ontogeny (Adams et al., 1987). Thus, RIP1-
Tag2 (abbreviated RT2) mice with embryonic onset
of Tag expression were found to establish systemic
tolerance toward Tag, whereas other lines of mice
with delayed onset of Tag expression developed a
spontaneous autoimmune response against their pan-
creatic/3 cells (Skowronski et al., 1990; Jolicoeur et
al., 1994; F6rster et al., 1995).
With the aim of generating Tag-specific TCR-
transgenic mice to study the mechanism of induction
of tolerance versus autoimmunity in this system, we
identified and cloned a MHC class II restricted Tag-
specific TCR that was expressed on Tag-specific
CD4 T cells isolated from pancreatic infiltrates of an
autoimmune RIP1-Tag5 mouse (F6rster et al., 1995).
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Genomic constructs encoding this Tag-specific TCR
were injected into fertilized mouse oocytes and two
independent lines of transgenic mice were obtained in
which either a single copy of the TCR c-chain gene
and two copies of the TCR/3-chain gene (TCR1 mice)
or multiple copies of both TCR c and/3 (TCR2 mice)
were cointegrated into the genome. With the help of
an anti-idiotypic antibody specific for the transgenic
TCR, it could be demonstrated that TCR1 mice
expressed the transgenic receptor on no more than
0.5% of thymocytes and 10% of peripheral CD4 T
cells, whereas the majority of peripheral T cells
expressed endogenous TCR. In contrast, TCR2 mice
carried the transgenic TCR on almost all thymocytes
and 90% of peripheral T cells (F6rster et al., 1995).
The reason for this differential expression of the
transgenic TCR in TCR1 versus TCR2 mice is
presently unknown but most likely depends on
position effects of the transgene integration site.
ESTABLISHMENT OF PERIPHERAL
TOLERANCE DEPENDS ON THE
FREQUENCY OF AUTOREACTIVE T CELLS
When the two different Tag-specific TCR-transgenic
lines were crossed to the tolerant RT2 line, we found
that only RT2/TCR1 mice established tolerance to
Tag, as evident by deletion of most of the transgenic
T cells and functional inactivation of the remaining
ones. In contrast, RT2/TCR2 double-transgenic mice
failed to develop peripheral T-cell tolerance. This
result could be attributed to the different frequencies
of autoreactive T cells in TCR1 versus TCR2 mice
rather than intrinsic differences between the two lines,
as demonstrated by two independent experimental
approaches. In the first series of experiments, the
frequency of Tag-specific T cells in TCR2 mice was
reduced by generation of mixed bone-marrow chi-
maeras in which bone marrow derived from TCR2
mice was mixed at various ratios with bone marrow
from nontransgenic mice and transferred into sub-
lethally irradiated RT2 or negative control mice.
Analyzing the tolerance status of these chimaeras,
we could demonstrate that transgenic (Id+) T cells
derived from TCR2 mice were susceptible to toler-
ance induction when present at low frequencies (i.e.,
less than 15% of peripheral CD4 T cells) (F6rster et
al., 1995). Conversely, in a different set of experi-
ments, the frequency of Id T cells in TCR1 mice was
increased to 100% by breeding of the TCR1 line into
the RAG-l-deficient background (Mombaerts et al.,
1992). Interestingly, even in the absence of endo-
genous TCR rearrangements, the absolute number of
transgenic T cells in TCR1/RAG-1 -/- mice remained
low, that is, the total number of thymocytes in these
mice was only 2-3 106 cells, and the number of
peripheral Id T cells in TCR1/RAG-1
-/- mice was
no more than a 4-5-fold increase over that in normal
TCR1 mice. Even though the increase in the absolute
number of Tag-specific T cells in TCR1/RAG-1
-/-
mice was moderate, RT2/TCR1 double-transgenic
mice in the RAG-1
-/- background developed an
autoimmune response that was more severe than the
one originally observed in RT2/TCR2 double-trans-
genic mice (F6rster and Lieberam, 1996).
As shown in Figures l(c) to (f), transgenic CD4
T cells as well as a few CD8 T cells expressing the
same MHC class II restricted TCR infiltrated into the
pancreatic islets and destroyed most of the Tag-
expressing/3 cells despite constitutive expression of
the viral oncogene, which in tolerant mice invariably
causes the formation of/3-cell tumors by the age of
10-12 weeks; for comparison, see Figures l(a) and
(b), depicting part of a tumorigenic islet in a tolerant
RT2/TCR1 mouse. Remarkably, the autoimmune
response in RT2/TCR1/RAG-1 -/- mice strongly
reduced or even prevented Tag-dependent tumor
formation, and in about one-third of the mice led to
the development of diabetes with blood glucose levels
higher than 300 mg/dl (Figure 2). Mice that did not
become diabetic remained normoglycemic during the
observation period (7-14 weeks of age), whereas
tolerant RT2/TCR1 mice older than 10 weeks inevita-
bly developed hypoglycemia due to the formation of
Tag-induced insulinomas (Figure 2).
The failure of tolerance induction in mice with a
high frequency of autoreactive CD4 T cells may be
explained by a limiting amount of the tolerizing
antigen expressed in peripheral tissues and the92 I. FORSTER.
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FIGURE 2 Development of diabetes in RT2/TCR1/RAG-1 -/-
mice. Shown are the blood glucose levels of groups of 7 TCR1/
RAG-I +, 10 RT2/TCR1/RAG-1 +, and 14 RT2/TCR1/RAG-1 -/-
mice. All mice were between 7 and 14 weeks of age. Development
of diabetes was observed both in young and older RT2/TCR1/
RAG- 1-/- mice.
ONTOGENETIC TIMING OF TOLERANCE
INDUCTION
Considering the substantial autoreactive potential of
the transgenic Tag-specific T cells, tolerant RT2/
TCR1 double-transgenic mice offer a unique poss-
ibility to unravel the naturally occurring mechanism
of peripheral CD4 T-cell tolerance induction. As
mentioned before, the initial analysis of adult RT2/
TCR1 mice demonstrated that the majority of Id T
cells in these mice were deleted and the remaining
Tag-specific T cells appeared functionally impaired.
By examining tolerance induction in adolescent mice,
we noticed that deletion of the autoreactive T cells
was not apparent before the age of 3 weeks (F6rster
and Lieberam, 1996). Rather, Id T cells derived from
mesenteric lymph nodes (LN) of 3-week-old RT2/
TCR1 mice were found to be normally responsive to
the Tag peptide (362-384) that is specifically recog-
nized by the transgenic TCR. Since Tag is expressed
in these mice starting from embryonic day 10, it was
important to assess whether the nontolerant Tag-
specific T cells in postnatal mice were ignorant of the
pancreatic Tag or were actively undergoing an
immune response. Indeed, upregulation of the early
activation marker CD69 (Testi et al., 1989) as well as
the memory T-cell marker CD44 (DeGrendele et al.,
1996) on Id T cells of RT2/TCR1 mice could be
noticed as early as 1 week after birth.
Consistent with activation, the Tag-specific T cells
also increased in size and downregulated the L-
selectin LN homing receptor. Activation was maximal
between 2 and 3 weeks of age, at which point
approximately two-thirds of the Id T cells expressed
the CD69 activation marker. Starting from 3 weeks of
age until adulthood, 80-90% of the transgenic T cells
were deleted from the peripheral lymphocyte pool,
whereas half of the remaining cells continued to
exhibit an activated phenotype. Analyses of cell
turnover by in vivo labeling with the thymidine
analogue bromodeoxyuridine were consistent with the
interpretation that most of the activated Id T cells in
adult mice represent relatively recent thymic emi-
grants with an average lifespan of 1 to 2 weeks
(F6rster and Lieberam, 1996, and unpublished data).
ARE DRAINING LYMPH NODES THE SITES
OF TOLERANCE INDUCTION?
The presence of activated CD69+, Tag-specific T cells
in mesenteric LN suggests that these cells may have
been stimulated by APC presenting the appropriate
Tag peptide in the LN themselves. Since expression
of the Tag transgene has not been detected in LN
(Jolicoeur et al., 1994), an alternative explanation
could be that APC internalize Tag protein in the
pancreas and migrate to the local draining LN. In the
human, the mesenteric LN as well as several other
peritoneal LN have been demonstrated to be within
the lymphoid drainage pathway of the pancreas
(Evans and Ochsner, 1954). Therefore, a panel of
different LN from various locations was examined for
the presence of activated Tag-specific T cells in the
early phase of tolerance induction. Interestingly,
CD69+Id T cells could be detected only in LN
located in the peritoneal cavity (mesenteric, infra-
pancreatic, and paraaortic LN) and to a lower extentCONTROLLING AUTOREACTIVITY OF CD4 T CELLS 93
in Peyer’s patches of the small intestine but not in
more remote locations like axillary, cervical, and
inguinal LN. Nevertheless, Tag-specific T cells iso-
lated from LN outside the peritoneal cavity expressed
slightly elevated levels of CD44 and were found to be
as unresponsive to Tag stimulation in vitro as
mesenteric LN cells (F6rster and Lieberam, 1996).
Since transient insulitis was observed in young
RT2/TCR1 mice prior to tolerance induction, it
cannot be excluded that the Tag-specific T cells had
been activated initially in the pancreas before they
reached the draining LN. However, the current
knowledge on the migration properties of lympho-
cytes (Smith and Ford, 1983; Mackay et al., 1990)
rather favors the hypothesis that naive Tag-specific T
cells first recognize their target antigen on APC
located in the draining LN of the pancreas before they
are enabled to enter the pancreatic tissue as activated
T cells. Following tolerance induction, some of the
transgenic T cells may then recirculate throughout the
immune system as CD69-negative, anergic cells with
slightly elevated expression of CD44.
CONCLUDING REMARKS
A key question concerning the mechanism of toler-
ance induction of CD4 T cells is how and where the
autoantigen is presented to the T cells. The model
proposed suggests that the antigen may be delivered
to the draining LN through uptake by local APC. This
pathway requires that some of the antigen must be
released from peripheral tissues, perhaps through
naturally occurring cell death (apoptosis) or by an
unknown mechanism of secretion of otherwise intra-
cellular proteins. In the case of Tag, it cannot be
excluded that the oncogenic activity of the protein
may aid in inducing cellular abnormalities in the
pancreatic /3 cells that promote uptake of Tag by
macrophages or dendritic cells. Lack of antigen
presentation in draining LN may prevent the induc-
tion of systemic tolerance and rather result in
immunologic ignorance, that is, failure to recognize
secluded antigens (Ohashi, 1994). As demonstrated
previously, activation of potentially autoreactive T
cells specific for such secluded antigens may cause
severe autoimmune responses (Ohashi et al., 1991;
Oldstone et al., 1991). Therefore, understanding the
mechanism of peripheral tolerance induction via
appropriate delivery of autoantigens to local LN may
be of major importance for the prevention of auto-
immune diseases.
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